(Q43582704)

24 November 2017

title

Vaccine safety versus vaccine efficacy in mass immunisation programmes (English)

1 reference

https://api.crossref.org/works/10.1016/0140-6736(91)92601-W

28 October 2022

1 reference

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1682694

28 October 2022

author name string

D. J. Nokes

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1682694

28 October 2022

R. M. Anderson

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1682694

28 October 2022

language of work or name

English

0 references

publication date

1 November 1991

1 reference

24 November 2017

23 November 1991

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1682694

full work available at URL

28 October 2022

https://api.elsevier.com/content/article/PII:014067369192601W?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0140-6736(91)92601-W

https://api.elsevier.com/content/article/PII:014067369192601W?httpAccept=text/plain

28 October 2022

1 reference

https://api.crossref.org/works/10.1016/0140-6736(91)92601-W

28 October 2022

1 reference

24 November 2017

volume

338

1 reference

24 November 2017

issue

8778

1 reference

24 November 2017

page(s)

1309-1312

1 reference

The epidemiology of mumps in the UK: a preliminary study of virus transmission, herd immunity and the potential impact of immunization

24 November 2017

cites work

2

1 reference

https://api.crossref.org/works/10.1016/0140-6736(91)92601-W

28 October 2022

3

1 reference

https://api.crossref.org/works/10.1016/0140-6736(91)92601-W

Serological study of the epidemiology of mumps virus infection in north-west England

28 October 2022

4

1 reference

https://api.crossref.org/works/10.1016/0140-6736(91)92601-W

Surveillance of antibody to measles, mumps, and rubella by age.

28 October 2022

5

1 reference

https://api.crossref.org/works/10.1016/0140-6736(91)92601-W

Modelling forces of infection for measles, mumps and rubella

28 October 2022

6

1 reference

https://api.crossref.org/works/10.1016/0140-6736(91)92601-W

The estimation of age-related rates of infection from case notifications and serological data

28 October 2022

7

1 reference

https://api.crossref.org/works/10.1016/0140-6736(91)92601-W

The immunizing effect and reactogenicity of two live attenuated mumps virus vaccines in Swedish schoolchildren

28 October 2022

11

1 reference

https://api.crossref.org/works/10.1016/0140-6736(91)92601-W

Evaluation in young children of the Urabe Am 9 strain of live attenuated mumps vaccine in comparison with the Jeryl Lynn strain

28 October 2022

12

1 reference

https://api.crossref.org/works/10.1016/0140-6736(91)92601-W

Comparison of the Urabe Am 9-Schwarz and Jeryl Lynn-Moraten combinations of mumps-measles vaccines in young children

28 October 2022

13

1 reference

https://api.crossref.org/works/10.1016/0140-6736(91)92601-W

A controlled trial for evaluating two live attenuated mumps-measles vaccines (Urabe Am 9-Schwarz and Jeryl Lynn-Moraten) in young children

28 October 2022

14

1 reference

https://api.crossref.org/works/10.1016/0140-6736(91)92601-W

Clinical trial of a new trivalent measles-mumps-rubella vaccine in young children

28 October 2022

16

1 reference

https://api.crossref.org/works/10.1016/0140-6736(91)92601-W

Interference between strains in live virus vaccines, I: Combined vaccination with measles, mumps and rubella vaccine

28 October 2022

20

1 reference

https://api.crossref.org/works/10.1016/0140-6736(91)92601-W

Vaccine induced mumps-like diseases

28 October 2022

23

1 reference

https://api.crossref.org/works/10.1016/0140-6736(91)92601-W

Measles-mumps vaccination in the FRG: an empirical analysis after 14 years of use. II. Tolerability and analysis of spontaneously reported side effects

28 October 2022

24

1 reference

https://api.crossref.org/works/10.1016/0140-6736(91)92601-W

Mumps vaccine complications: which strain?

28 October 2022

25

1 reference

https://api.crossref.org/works/10.1016/0140-6736(91)92601-W

Mumps, measles, and rubella vaccination and encephalitis

28 October 2022

26

1 reference

https://api.crossref.org/works/10.1016/0140-6736(91)92601-W

Changes of the immunological patterns against measles, mumps and rubella. A vaccination programme studied 3 to 7 years after the introduction of a two-dose schedule

28 October 2022

27

1 reference

https://api.crossref.org/works/10.1016/0140-6736(91)92601-W

Clinical mumps vaccine efficacy.

28 October 2022

28

1 reference

https://api.crossref.org/works/10.1016/0140-6736(91)92601-W

The use of mathematical models in the epidemiological study of infectious diseases and in the design of mass immunization programmes

28 October 2022

29

1 reference

https://api.crossref.org/works/10.1016/0140-6736(91)92601-W

28 October 2022

Identifiers

1 reference

24 November 2017

1 reference